Waters Corporation (NYSE:WAT) introduces the DynaPro™ ZetaStar™ instrument from its Wyatt Technology™ portfolio for nanoparticle analysis.
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases has launched an on-site dialysis program with Sarah Bush Lincoln, a regional health system in Mattoon, IL.
Andersen Sterilizers and its sister company, contract sterilization specialist Andersen Scientific, were awarded the very first master file in the FDA's 510(k) Ethylene Oxide (EO) Sterility Change Master File Pilot Program.
In a groundbreaking development, India-based company Voxelgrids has launched an advanced and affordable MRI scanner with the potential to revolutionize healthcare accessibility not only in India but also worldwide.
By order of a U.S. bankruptcy court, Tiger Group and Liquidity Services on Aug. 10 will auction OncoSec Medical Inc.'s former immunotherapy laboratory and R&D facility in San Diego.
In a landmark decision, the U.S. Food and Drug Administration (FDA) has approved the first at-home oral pill, zuranolone, which will be sold under the brand named Zurzuvae, for treating perinatal or postpartum depression (PPD) – a condition one in eight birthing women experience.
JIYA Facial Cosmetic Surgery is delighted to offer their patients the latest innovation in laser treatments to produce a more youthful and healthy appearance with noticeable results in just one session.
Ceek Women's Health, an award-winning medical device company, is proud to introduce the Nella Single-Use Vaginal Speculum with Integrated Sidewall Retractors and LED Light.
A new genomic urine test can help doctors accurately predict bladder cancer as many as 12 years before clinical signs and symptoms emerge and long before a diagnosis can be made with cystoscopy, the most common method of detection, according to a new study*.
Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, supports the recent American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) position statement.